Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells
about
A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment.Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepiloneGambogenic acid alters chemosensitivity of breast cancer cells to AdriamycinTumor-targeting, pH-sensitive nanoparticles for docetaxel delivery to drug-resistant cancer cellsMiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer.Role of miR-155 in drug resistance of breast cancer.MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.miRNA-34a is associated with docetaxel resistance in human breast cancer cells.Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells.Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis.Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737.Genomic signatures of breast cancer metastasis.Identification of zinc finger protein of the cerebellum 5 as a survival factor of prostate and colorectal cancer cells.Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.
P2860
Q33949801-F558948D-D3BC-4111-BC16-1E51DC6E0E4AQ34274930-0B0C1A2C-9977-4A3F-9373-92298017F353Q35661283-C9DEE892-765E-4BF5-A1A5-48FBC2BC5FFCQ36003575-B4FA502C-4D79-47AA-8D66-A8148D6253FAQ36186458-02A78E6A-910F-4D38-83EA-8EE684B9027AQ36874767-064AF7C2-4121-4518-95DC-72DB05BE9166Q36955104-C2A78E01-3A5D-4E08-87D3-3745E436AD57Q38368383-CF6DB0FF-6EAE-4294-B771-34E44B9114B2Q39433284-10ED1943-772C-4C7D-B17B-C79382BE6260Q39463711-F042125B-C37C-4AA2-B2A7-0E87908BFCF2Q39576802-96B5C7CD-D1C3-4CB5-BF74-A3D33497A088Q40105899-E9F05406-DE72-442F-96B9-9FCCC7E391F1Q40209240-949C14EA-5D99-4F05-A9D7-5FF1DF2BBAEBQ41847989-093E6440-E193-478C-B730-20F3F4A48EDDQ42259243-92A69C0A-293C-4C77-8EE4-9980164FE714Q47100299-FCB317CF-559A-4EFE-B4E0-A2F1FAA646AEQ50133722-42A0AB4E-4892-4035-9875-7E3E65473F19
P2860
Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Reduced expression of p27 is a ...... istance in breast cancer cells
@ast
Reduced expression of p27 is a ...... istance in breast cancer cells
@en
Reduced expression of p27 is a ...... istance in breast cancer cells
@nl
type
label
Reduced expression of p27 is a ...... istance in breast cancer cells
@ast
Reduced expression of p27 is a ...... istance in breast cancer cells
@en
Reduced expression of p27 is a ...... istance in breast cancer cells
@nl
prefLabel
Reduced expression of p27 is a ...... istance in breast cancer cells
@ast
Reduced expression of p27 is a ...... istance in breast cancer cells
@en
Reduced expression of p27 is a ...... istance in breast cancer cells
@nl
P2093
P2860
P356
P1476
Reduced expression of p27 is a ...... istance in breast cancer cells
@en
P2093
Andrew C Schofield
Andrew W Hutcheon
Iain Brown
Kawan Shalli
Sarah L McDonald
Steven D Heys
Susan E Moir
P2860
P2888
P304
P356
10.1186/BCR918
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1008581850